TOP STORIES

• BUSINESS Can Daiichi Sankyo Take Big Leap in Oncology with 3 FDA Nods in FY2019?
  January 4, 2019

• BUSINESS Reata Developing Sakigake Designated DKD Drug for Alport Syndrome in Japan
  December 28, 2018

• BUSINESS Biogen Japan Set to “Make Impossible Possible” in Next 5 Years, Double Neuroscience Pipeline
  December 27, 2018

• TRENDS Top 10 PHARMA JAPAN Stories in 2018
  December 26, 2018

• BUSINESS Some Drug Makers Stop Distributing 2019 Calendars with Revised JPMA Code of Practice Set to Take Effect in January
  December 25, 2018

• REGULATORY MHLW OKs Add’l Indications for Keytruda, Tecentriq, Hemlibra, and More
  December 25, 2018

• REGULATORY After Settling on October 2019 Re-Pricing, When Will Govt Reveal New Drug Prices?
  December 21, 2018

• REGULATORY PhRMA, EFPIA Pitch Enhanced Appraisal Model for Japan HTA Plan; Chuikyo Reps Acknowledge ICER Limitations
  December 20, 2018

• REGULATORY Govt to Pare Drug Prices by 2.4% in October 2019 Ad-Hoc Re-Pricing
  December 19, 2018

• BUSINESS Takeda Likely to Make NYSE Debut on Christmas Eve
  December 19, 2018

• REGULATORY Ministers Agree on Ad-Hoc Drug Re-Pricing in October 2019, 29 Billion Yen Saving in State Coffers
  December 18, 2018

• COMMENTARY LDP Draws Up Tax Reform Outline, Revamps Credits for R&D Expenses
  December 17, 2018

• BUSINESS Astellas Makes Full Inroads into I/O Arena with Potenza Buyout
  December 17, 2018

• BUSINESS Lundbeck Japan to Quadruple Workforce by Next Summer, Eyes Vortioxetine Launch: Chief
  December 14, 2018

• BUSINESS Astellas CEO Sees Cell Therapy Biz Model Established by “around 2030”
  December 14, 2018

• REGULATORY Govt to Tap R&D Tax Credit System to Push Research on Pediatric Use, Superbug Fight
  December 13, 2018

• REGULATORY Chuikyo Adopts Outline of 2019 Drug Price Revision for Sales Tax Hike
  December 13, 2018

• BUSINESS Armed with 2 New Drugs, EA Pharma Looks to Raise Profile in Chronic Constipation Space
  December 12, 2018

• REGULATORY MHLW to Offer Free Rubella Shots to Men Aged 39-56
  December 12, 2018

• REGULATORY Govt’s Draft Reform Timeline Prods MHLW to Discuss Use of “Economic Evaluations” in Reimbursement Decisions in FY2019
  December 11, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 127
• 128
• 129
• 130
• 131
• 132
• 133
• 134
• 135
• …
• Next ›
• 最終 »